Skip to content
Trial Eligibility
Menu

Developing and Testing Health Warning Labels on the ENDS Device

NCT04907136

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Electronic Cigarette Use

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 35 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Florida International University
Last updated on ClinicalTrials.gov
June 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Florida International University · Miami, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.